France hospital covid-19 patient France

COVID-19 Scan for Nov 23, 2021

Reading now: 405

Study: No risk of serious adverse events in elderly COVID vaccine recipients A new nationwide study in France involving people 75 years or older found no increase in acute myocardial infarction, stroke, or pulmonary embolism 14 days following each Pfizer-BioNTech COVID-19 vaccine dose.

The data was published as a research letter yesterday in JAMA.To estimate the risk of acute myocardial infarction, hemorrhagic stroke, ischemic stroke, or pulmonary embolism in this age-group, researchers looked at unvaccinated and vaccinated adults 75 or older admitted to the hospital with these conditions between Dec 15, 2020, and Apr 30, 2021, throughout France.The authors found that over the observation period, 11,113 persons 75 years or older were

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News